Important - Patient Notice - The practice will be closed for training on Thursday 14th May from 1pm to 5.30pm. During this period please call NHS111, or in the event of a medical emergency call 999
Sorry, we're currently closed. Please call NHS 111
Patient Participation Group Autumn Newsletter 2025 Prescribing of Tirzepatide/Mounjaro Men’s Health Week: Reducing Risk of Type 2 Diabetes With Healthy Lifestyle Changes – FREE WEBINAR Closure of Everest House Pharmacy Young People’s Event Pharmacy First You can now see and access your prescriptions electronically in the NHS App….. Measles Infection Booking an Appointment for a Blood Test MMR Vaccine – Protect Yourself and Your Family
NHS England and NICE have approved the use of Tirzepatide, which you may also know as Mounjaro® or ‘the weight loss drug’, from primary care.
You may well hear that Tirzepatide is available from primary care from 23rd June 2025. However, in the first two years entry criteria have been set by NHS England to a very small number of people. This is to allow safe entry of this repurposed medicine into the health system.
Please only contact us if you are eligible, this means you have a BMI of 40 or higher and at least four of these additional conditions, which will already have been diagnosed by your GP or another medical professional: